Qube Research & Technologies (QRT)
NVO

Qube Research & Technologies (QRT)’s Novo Nordisk NVO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-171,416
Closed -$8.12M – 3940
2025
Q4 		$8.72M Buy
+171,416
New +$8.77M 0.01% 1435
2025
Q2 		– Sell
-883,125
Closed -$60.1M – 3838
2025
Q1 		$61.3M Buy
883,125
+27,983
+3% +$2.31M 0.07% 339
2024
Q4 		$73.6M Buy
855,142
+192,899
+29% +$20.9M 0.1% 263
2024
Q3 		$78.9M Sell
662,243
-64,399
-9% -$8.59M 0.12% 210
2024
Q2 		$104M Buy
726,642
+6,511
+0.9% +$863K 0.16% 144
2024
Q1 		$92.5M Buy
720,131
+362,361
+101% +$43.1M 0.15% 173
2023
Q4 		$37M Sell
357,770
-236,554
-40% -$23.4M 0.07% 332
2023
Q3 		$54M Buy
594,324
+288,252
+94% +$25.4M 0.14% 186
2023
Q2 		$24.8M Buy
+306,072
New +$25M 0.09% 290
2022
Q4 		– Sell
-99,716
Closed -$4.97M – 2839
2022
Q3 		$4.97M Sell
99,716
-115,796
-54% -$6.2M 0.03% 623
2022
Q2 		$12M Buy
+215,512
New +$12M 0.09% 277
2022
Q1 		– Sell
-5,108
Closed -$286K – 2829
2021
Q4 		$286K Sell
5,108
-117,842
-96% -$6.38M ﹤0.01% 1825
2021
Q3 		$5.9M Buy
+122,950
New +$5.94M 0.07% 348
2021
Q2 		– Sell
-72,718
Closed -$2.45M – 2639
2021
Q1 		$2.45M Sell
72,718
-27,256
-27% -$971K 0.04% 569
2020
Q4 		$3.49M Sell
99,974
-29,510
-23% -$1.02M 0.05% 418
2020
Q3 		$4.5M Sell
129,484
-46,360
-26% -$1.55M 0.06% 391
2020
Q2 		$5.76M Buy
+175,844
New +$5.61M 0.08% 307
2020
Q1 		– Sell
-24,714
Closed -$715K – 1488
2019
Q4 		$715K Sell
24,714
-7,770
-24% -$215K 0.02% 774
2019
Q3 		$840K Buy
+32,484
New +$821K 0.56% 46
2018
Q2 		– Sell
-98
Closed -$2K – 898
2018
Q1 		$2K Buy
+98
New +$2.57K ﹤0.01% 326

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NVO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 171,416 shares — an estimated $8.12M sold.

Qube Research & Technologies (QRT) first reported a position in NVO in Q1 2018 and held it in 20 quarters. The position peaked at $104M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 171,416 Novo Nordisk shares in Q1 2026, an estimated $8.12M.
  • Qube Research & Technologies (QRT) first reported a position in Novo Nordisk in Q1 2018 and held it in 20 quarters.
  • Qube Research & Technologies (QRT)'s Novo Nordisk position peaked at $104M in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.